Physician profile
Candice Mccool
NPI 1104224294
$1,375.21
in general payments reported to CMS, 2019-2025
15 companies · $1,344 in 2025
The $1,344 reported for 2025 was more than what 91% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $31.19 · 2025: $1,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $382.38 | 2025 | Airsupra, Fasenra, Tezspire |
| Genzyme Corporation | $238.89 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $160.94 | 2025 | Aralast, Cuvitru |
| Incyte Corporation | $159.31 | 2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $72.59 | 2025 | |
| Grifols USA, LLC | $68.58 | 2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $64.99 | 2025 | Dupixent |
| Genentech USA, INC. | $62.54 | 2025 | Xolair |
| Csl Behring | $41.60 | 2025 | Hizentra |
| Inari Medical, INC. | $31.19 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lilly USA, LLC | $24.90 | 2025 | Ebglyss |
| Ars Pharmaceuticals Operations, INC. | $19.00 | 2025 | Neffy |
| Amgen INC. | $17.44 | 2025 | Tezspire |
| Paratek Pharmaceuticals, INC. | $15.77 | 2025 | Nuzyra, Xhance |
| Galderma Laboratories, L.P. | $15.09 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Mccool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.